Compugen (NASDAQ:CGEN) is scheduled to be issuing its quarterly earnings data before the market opens on Monday, May 20th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter.
Compugen (NASDAQ:CGEN) last released its quarterly earnings results on Tuesday, February 26th. The biotechnology company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.05. On average, analysts expect Compugen to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
CGEN stock opened at $3.58 on Monday. The company has a market capitalization of $183.62 million, a PE ratio of -8.73 and a beta of 2.43. Compugen has a 12 month low of $2.00 and a 12 month high of $4.31.
CGEN has been the topic of several research reports. Zacks Investment Research upgraded shares of Compugen from a “hold” rating to a “strong-buy” rating and set a $4.00 price target on the stock in a research report on Friday, March 1st. Oppenheimer set a $9.00 price objective on shares of Compugen and gave the company a “buy” rating in a research note on Tuesday, February 26th.
WARNING: “Compugen (CGEN) Scheduled to Post Quarterly Earnings on Monday” was first posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2019/05/13/compugen-cgen-scheduled-to-post-quarterly-earnings-on-monday.html.
Compugen Company Profile
Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's therapeutic pipeline consists of immuno-oncology programs against novel drug targets in the areas of unmet medical needs in various cancer types and patient populations.
Further Reading: How to Track your Portfolio in Google Finance
Receive News & Ratings for Compugen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugen and related companies with MarketBeat.com's FREE daily email newsletter.